Humanoid Raises $152 Million at $1.35 Billion Post-Money Valuation, Becoming Europe's First Pure-Play Humanoid Robotics Unicorn
23.7.2026 15:00:00 CEST | Business Wire | Press release
Humanoid announces its Series A investment round, reaching a $1.35 billion valuation just two years after founding.It is the largest ever Series A for a humanoid-first robotics company in Europe, positioning Humanoid as the leading humanoid-first robotics unicorn in the UK and continental Europe.The new capital will accelerate Humanoid's next-generation robot development, commercial deployments with global industrial leaders, and evolution of the proprietary AI platform on the path toward general-purpose humanoids.The investment marks a defining moment for Europe's tech ecosystem, showing that globally competitive Physical AI companies can be built and scaled in Europe.
Humanoid, a UK-based AI and robotics company building industrial humanoid robots, announced a $152 million Series A financing at a $1.35 billion post-money valuation. This funding brings the total amount raised to date to $270 million. The round was led by Prime Movers Lab, a venture capital firm focused on investments in breakthrough scientific startups working to revolutionize the world's most important industries and transform billions of lives, with participation from Schaeffler, Bosch, Fubon Financial Holding Venture Capital, and Aglaé Ventures.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260723238282/en/

Humanoid's leadership team with representatives from Prime Movers Lab, the lead investor in Humanoid's Series A financing.
Now is a defining moment for the European technology ecosystem which positions the region among the global leaders in one of the world's fastest-growing tech sectors. Until now, much of the Physical AI momentum has been concentrated in the United States and China. The investment demonstrates that the UK and continental Europe can produce and scale globally competitive humanoid robotics companies at the cutting-edge of the field.
The new capital will fund Humanoid's next phase of growth, strengthening its technology leadership and accelerating its commercial deployments and business expansion. The company will focus on:
- Development and launch of its next-generation humanoid robotics platform;
- Long-term commercial deployments at customer facilities across logistics, manufacturing, retail, and other sectors, beginning with the roll-out of Beta version robots in Q4 2026;
- Start of mass manufacturing of wheel-based humanoid robots;
- AI and software development, including Humanoid's proprietary AI brain KinetIQ, on our way toward a general-purpose robot for industrial applications.
Humanoid has become one of the fastest-growing companies in the industry and secured major partnerships with Fortune 500 companies, including SAP, NVIDIA, Bosch, and Siemens. Most notably, Humanoid recently signed the industry's largest publicly announced commercial agreement with Schaeffler for the large-scale deployment of thousands of humanoid robots in manufacturing environments.
“In just two years, we've gone from an idea to becoming Europe's first pure-play humanoid robotics unicorn, partnered with some of the world's leading industrial companies and built one of the strongest pipelines in the industry. What we've accomplished in such a short time would typically take a decade. None of this would have been possible without an extraordinary team that challenges every single day what people believe is possible. This funding gives us the resources to move even faster and to turn humanoid robots from breakthrough technology into everyday industrial tools,” noted Artem Sokolov, Founder and CEO of Humanoid.
"Humanoid robotics will be one of the defining technologies of the next decade, reshaping how commercial and industrial work gets done. We expect the field to consolidate around a handful of category leaders across the US, Europe, and China. Humanoid AI will be one of a small cadre of robotics companies that will define humanoid robotics in Europe and beyond," said Zia Huque, General Partner at Prime Movers Lab.
Klaus Rosenfeld, CEO of Schaeffler AG, commented: “Humanoid robotics is rapidly moving from a visionary concept to an industrial reality, and Schaeffler, as a leading motion technology company, is uniquely positioned to help shape this evolution. By combining our decades of industrial expertise and manufacturing excellence with Humanoid’s breakthrough physical AI platform, we are actively backing one of the most exciting frontiers in technology. We are proud to support Humanoid as both a strategic investor and a commercial partner as they scale a technology that holds the power to fundamentally redefine productivity across global industries.”
“We see significant growth opportunities in the field of humanoid robotics. Through our subsidiary Robert Bosch Robotics GmbH we have already entered into a manufacturing partnership with Humanoid. Bosch will act as Humanoid's contract manufacturing partner, while also providing strategic consulting and technical expertise in hardware design, production, and supply chain,” noted Mathias Pillin, Chief Technology Officer of Robert Bosch GmbH.
"Humanoid has demonstrated exceptional execution in a remarkably short period of time, transforming breakthrough AI and robotics technology into real industrial deployments. We are excited to support the company's next stage of growth as a long-term strategic partner and look forward to contributing to its global expansion,” Fubon Financial Holding Venture Capital said.
The valuation reflects both Humanoid's speed of execution and growing market confidence that humanoid robots are becoming commercially viable. What was once considered a long-term research experiment is now a deployable industrial technology. With its wheeled robots, Humanoid aims to address global labor shortages across manufacturing, logistics and other critical sectors, solving real operational problems for its customers.
The company's vertically integrated approach combines proprietary robotics hardware with its own AI brain, KinetIQ, which enables robots to understand, reason, and execute complex physical tasks in real industrial environments. With this financing, Humanoid aims to accelerate the transition toward a future where intelligent robots work safely alongside people across the world's industrial economy.
About Humanoid
Humanoid is a UK-based robotics company building humanoid robots for industrial use. Founded by Artem Sokolov in 2024, Humanoid brings together over 250 engineers, researchers, and innovators from top global tech companies. All robots run on KinetIQ, Humanoid’s proprietary four-layer AI framework designed for real-world deployment.
With offices in London, Boston, Vancouver, and San Diego, the company is focused on building commercially viable, scalable, and safe robotic solutions for real-world applications.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260723238282/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. Federal Court Permanently Bans 19 Online Sellers of Fake Urolithin A Supplements and Awards $5.3 Million in Damages to Timeline23.7.2026 16:27:00 CEST | Press release
Default judgment follows Timeline’s independent laboratory testing showing products sold under 19 online brands contained no detectable Urolithin A, or far less than advertised Timeline (Amazentis SA), the Swiss life-sciences company that pioneered the postbiotic ingredient Urolithin A and its branded form Mitopure®, together with its U.S. subsidiary Timeline Longevity, Inc., announced today that the U.S. District Court for the District of Massachusetts has granted the companies’ motion for default judgments and permanent injunctions against 19 online sellers found to have marketed and sold nutritional supplements falsely advertised as containing Urolithin A. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722951066/en/ Timeline longevity supplement powered by Mitopure; proprietary, highly pure Urolithin A. The order, entered July 15, 2026 by Judge Myong J. Joun in Amazentis SA et al. v. The Partnerships and Unincorporated
TestMu AI Introduces the Source-to-Verdict Loop in Kane CLI, Carrying Every Requirement to a Ship Decision With Portable Proof23.7.2026 15:45:00 CEST | Press release
Kane CLI now takes a requirement all the way to a ship-or-hold verdict, designing the tests, running them in a real browser, and emitting an open .evidence proof pack that teammates, AI agents, and auditors can all verify, with no server or dashboard required TestMu AI (formerly LambdaTest), the world's first Agentic AI-powered Quality Engineering platform, introduced a source-to-verdict loop in Kane CLI, its natural-language testing tool. Building on Kane CLI's evolution from a browser automation tool, the loop carries a product requirement to a ship decision, writing the tests, running them in the local browser, collecting the proof, measuring coverage from what actually happened, and returning a verdict. As AI agents write, run, and fix tests, a green checkmark is no longer enough: a step that checks nothing passes, a test written against a spec that changed weeks ago passes, and an agent that says “done” without the click ever landing passes. Empty green and earned green are the sa
Norway’s health system adopts Wolters Kluwer UpToDate Enterprise Edition23.7.2026 15:30:00 CEST | Press release
Enterprise Clinical Decision Support solution available to 30,000 clinicians in more than 50 Norwegian hospitals Wolters Kluwer Health announced that Norway’s health system has renewed its adoption of UpToDate Enterprise Edition, a market-leading Clinical Decision Support (CDS) solution, for its nationwide health system which includes over 50 public hospitals and 11,000 beds in over 20 trusts. This extends a 15 year partnership with Helsebiblioteket, now part of the Norwegian Institute of Public Health (NIPH). Helping clinicians on a national scale Kjell Tjensvoll, Team Leader for Helsebiblioteket said, ‘‘Providing frontline teams with easy access to the latest medical knowledge is vital in reducing unwarranted variation and improving patient care on a national scale. UpToDate Enterprise Edition enables this, and we are delighted to strengthen our relationship with Wolters Kluwer and provide continued support for clinicians across the country.’’ UpToDate Enterprise Edition was selected
Boyd Watterson Global Names John Creswell Global Chief Client Officer to Accelerate Global Growth and Client Engagement23.7.2026 15:00:00 CEST | Press release
Veteran investment management executive will lead global sales, client engagement and marketing as Boyd Watterson Global continues expanding its global alternatives platform across real estate, infrastructure, and debt strategies. Boyd Watterson Global today announced the appointment of John Creswell as Global Chief Client Officer, a newly created senior leadership role that reflects the firm's continued investment in growth and its evolution into a leading global alternatives investment platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722823117/en/ John Creswell has joined Boyd Watterson Global as Global Chief Client Officer, a newly created role overseeing global sales, client engagement and marketing across the U.S., Europe and APAC. In this role, Creswell will oversee global sales, client engagement and marketing efforts across the United States, Europe and APAC, helping investors access the firm's capabilitie
Trulioo Launches AI Agent to Resolve Beneficial Ownership Where Global Registries Fall Short23.7.2026 15:00:00 CEST | Press release
Breakthrough AI agent reconstructs ownership for long-tail businesses and hard-to-reach jurisdictions while significantly increasing UBO coverage Trulioo, a global risk intelligence platform, today announced the UBO Discovery Agent, the newest layer in Trulioo's UBO Discovery capability inside its business risk and Know Your Business (KYB) verification workflow. AI is reshaping fraud, making it easier for bad actors to hide, and harder for companies to catch them. This makes the already tough job of verifying who actually owns a business even more difficult. Determining a business's ultimate beneficial owner is an ongoing, acute challenge for companies: registry coverage is inconsistent across countries, and even where registries exist, they typically record shareholders and directors of record (rather than the people actually in control). That data isn't simply outdated, it reflects a structural lag: ownership changes and time passes before the filing is made and processed, so a looku
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom